Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?-Reference-Cited by-同舟云学术

Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?

Published:2024-10 Issue:10 Volume:32 Page:1346-1351
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Eckstein Felix,Wisser Anna^ORCID,Maschek Susanne,Wirth Wolfgang^ORCID,Ladel Christoph^ORCID,Bihlet Asger Reinstrup,Knight Chris,Somberg Kenneth,Zhao Luping

Publisher

Elsevier BV

Reference15 articles.

1. Blinding images to sequence in osteoarthritis: evidence from other diseases;Felson;Osteoarthr Cartil,2009

2. Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis;Hochberg;JAMA,2019

3. Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study;Eckstein;Ann Rheum Dis,2021

4. Detection of differences in longitudinal cartilage thickness loss using a deep-learning automated segmentation algorithm: data from the foundation for the national institutes of health biomarkers study of the osteoarthritis initiative;Eckstein;Arthritis Care Res,2022

5. Automated MRI assessment confirms cartilage thickness modification in patients with knee osteoarthritis: post-hoc analysis from a phase II sprifermin study;Brett;Osteoarthr Cartil,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment – A post-hoc analysis from the phase 2B FORWARD study;Osteoarthritis and Cartilage Open;2024-12